Toggle Offcanvas
...
 
Dolutegravir Tenders

Dolutegravir Tenders

View Dolutegravir tenders, RFPs and contracts. Bid on readily available Dolutegravir tenders with the best and most comprehensive tendering platform, since 2002.

Bidding for Dolutegravir tenders is extremely lucrative for companies of all sizes. Tendering authorities and private companies release thousands of contracts worth millions for procurement of Dolutegravir.

Global Tenders stands out as the largest platform dedicated to pharmaceutical tenders and government contracts. Boasting over 20 years of experience in the tender business, GlobalTenders offers the most extensive and reliable Tenders/RFPs/Contracts Database available. The platform aggregates contracts from both public and private sources, connecting with a vast network of over half a million buyers. Employing advanced artificial intelligence, our meticulous process involves gathering information from over a hundred thousand sources. The data is then intelligently categorized into thousands of subcategories for easy filtering and presenting it in a user-friendly format for quick comprehension.

In addition to tender information, we offer in-depth Dolutegravir market analysis, bid consultancy services, and insights into top bidders and winners.

Sign up now to get instant access to unlimited Dolutegravir tenders, advanced search filters, market analysis, industry trends, tender training and 24/7 customer support.

21 Live Notices for Dolutegravir Tenders

Showing 1 to 21

Join Technical And Administrative Efforts In Order To Advance The Selection Processes For The Supply Of High Quality Medicines And Medical-Surgical Supplies Required To Meet The Necessities
country Colombia
posting date06 Feb 2025
deadline20 Feb 2025
Specific Contract For The Supply Of The Drug “Dolutegravir + Lamivudine 50 Mg/300 Mg”, Required By Asst Santi Paolo E Carlo In Milan, Carried Out Using The Sintel Telematic Platform, Aria2020305 “Dynamic Acquisition System For The Assignment Of Supplies Of Pharmaceutical Products”. Supply Period 12 Months From The Award, With The Option Of Renewal For A Further 6 Months And With An Express Termination Clause In The Event Of Activation Of The Relevant Centralized Agreement By Consip S.P.A. And/Or Aria S.P.A. Cig B57Fbd41E6
country Italy
posting date05 Feb 2025
deadline12 Feb 2025
Open House Original Discount Agreements 2025-06 - Dolutegravir
country Germany
posting date22 Jan 2025
deadline28 Feb 2027
Open House Original Discount Agreements 2025-07 - Lamivudine/Abacavir/Dolutegravir (Active Ingredient Combination)
country Germany
posting date22 Jan 2025
deadline28 Feb 2027
Open House Original Discount Agreements 2025-07 - Lamivudine/Abacavir/Dolutegravir (Active Ingredient Combination)
country Germany
posting date22 Jan 2025
deadline28 Feb 2027
Open House Original Discount Agreements 2025-06 - Dolutegravir
country Germany
posting date22 Jan 2025
deadline28 Feb 2027
Antiretrovirals 2025
country Uruguay
posting date31 Dec 2024
deadline12 Feb 2025
Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredients Dolutegravir And Rilpivirine (J05Ar21) Within The Framework Of A So-Called Open-House Model.
country Germany
posting date14 Jun 2024
deadline31 May 2026
Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredients Dolutegravir And Rilpivirine (J05Ar21) Within The Framework Of A So-Called Open-House Model.
country Germany
posting date12 Jun 2024
deadline31 May 2026
Open House Contracts For Several Active Ingredients/Combinations Of Active Ingredients
country Germany
posting date14 May 2024
deadline04 May 2026
Open House Original Discount Agreements 2023-32 - Dolutegravir/Rilpivirine (Combination Of Active Ingredients)
country Germany
posting date15 Sep 2023
deadline31 Oct 2025
Open House Original Discount Agreements 2023-32 - Dolutegravir/Rilpivirine (Combination Of Active Ingredients)
country Germany
posting date13 Sep 2023
deadline31 Oct 2025
Open House Original Discount Agreements 2023-29 - Dolutegravir/Lamivudine (Combination Of Active Ingredients)
country Germany
posting date13 Sep 2023
deadline31 Oct 2025
Open House Original Discount Agreements 2023-29 - Dolutegravir/Lamivudine (Combination Of Active Ingredients)
country Germany
posting date11 Sep 2023
deadline31 Oct 2025
Completion Of A Non-Excl. Discount Agreement According To § 130C Paragraph 1 Sgb V For Lamivudine And Dolutegravir, Atc Code: J05Ar25 For The Period From September 1St, 2023 To August 31St, 2025
country Germany
posting date09 Aug 2023
deadline04 Jul 2025
Completion Of A Non-Excl. Discount Agreement According To § 130C Paragraph 1 Sgb V For Lamivudine And Dolutegravir, Atc Code: J05Ar25 For The Period From September 1St, 2023 To August 31St, 2025
country Germany
posting date08 Aug 2023
deadline04 Jul 2025
Procurement Of Dolutegravir And Efavirenz
country Philippines
posting date27 Jan 2025
deadline18 Feb 2025
Dolutegravir Tablets 50 Mg
country India
posting date10 Feb 2025
deadline25 Feb 2025
D Re 96 Tab Dolutegravir 50Mg Lamivudine 300Mgtenofovir 300Mg,D Re 96 Closed Circuit For Anaesthesi Quantity: 2222
country India
posting date10 Feb 2025
deadline01 Mar 2025
Rc/24-25/347
country India
posting date27 Jan 2025
deadline21 Feb 2025

Share Share this page